Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (394)
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,700
Price
$0.35
Total Value
$945.00
Shares Held After
36,899
% of Holdings
7.3%
Phio Pharmaceuticals Corp. (PHIO)
Plott Ronald Todd — Director
Shares
15,000
Price
$1.14
Total Value
$17.10K
Shares Held After
15,000
% of Holdings
100.0%
Z Squared Inc. (ZSQR)
Schadel Christopher Ryan — Chief Marketing Officer
Shares
1,000
Price
$3.92
Total Value
$3.92K
Shares Held After
1,000
% of Holdings
100.0%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
10,000
Price
$1.06
Total Value
$10.60K
Shares Held After
431,421
% of Holdings
2.3%
SeaStar Medical Holding Corp (ICU)
Messinger Michael — Chief Financial Officer
Shares
750
Price
$3.27
Total Value
$2.45K
Shares Held After
2,500
% of Holdings
30.0%
EyePoint, Inc. (EYPT)
Zaderej Karen L. — Director
Shares
10,600
Price
$4.93
Total Value
$52.26K
Shares Held After
49,100
% of Holdings
21.6%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
2,030
Price
$4.92
Total Value
$9.99K
Shares Held After
8,587
% of Holdings
23.6%
Verrica Pharmaceuticals Inc. (VRCA)
Kirby John J. — Interim CFO
Shares
5,000
Price
$4.93
Total Value
$24.65K
Shares Held After
23,962
% of Holdings
20.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
9,000
Price
$5.54
Total Value
$49.86K
Shares Held After
3,096,000
% of Holdings
0.3%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
10,000
Price
$11.03
Total Value
$110.30K
Shares Held After
251,000
% of Holdings
4.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.27
Total Value
$10.27K
Shares Held After
19,592
% of Holdings
5.1%
Verrica Pharmaceuticals Inc. (VRCA)
Zawitz David — Chief Operating Officer
Shares
6,000
Price
$4.98
Total Value
$29.88K
Shares Held After
27,000
% of Holdings
22.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
4,200
Price
$4.91
Total Value
$20.62K
Shares Held After
6,557
% of Holdings
64.1%
Verrica Pharmaceuticals Inc. (VRCA)
Rieger Jayson — Director
Shares
5,000
Price
$4.91
Total Value
$24.55K
Shares Held After
207,593
% of Holdings
2.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
2,472
Price
$4.04
Total Value
$10.00K
Shares Held After
583,531
% of Holdings
0.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,400
Price
$0.93
Total Value
$5.02K
Shares Held After
381,115
% of Holdings
1.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
3,000
Price
$4.37
Total Value
$13.12K
Shares Held After
3,087,000
% of Holdings
0.1%
Kura Oncology, Inc. (KURA)
WILSON TROY EDWARD — Director
Shares
100,000
Price
$11.12
Total Value
$1.11M
Shares Held After
379,194
% of Holdings
26.4%
Zentalis Pharmaceuticals, Inc. (ZNTL)
WALTERS GROUP — 10% Owner
Shares
4,335,000
Price
$3.50
Total Value
$15.17M
Shares Held After
17,844,973
% of Holdings
24.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
11,608
Price
$2.09
Total Value
$24.21K
Shares Held After
2,760,000
% of Holdings
0.4%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
900
Price
$246.91
Total Value
$222.22K
Shares Held After
2,900
% of Holdings
31.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
1,100
Price
$245.85
Total Value
$270.44K
Shares Held After
2,000
% of Holdings
55.0%
MapLight Therapeutics, Inc. (MPLT)
Catalyst4, Inc. — 10% Owner
Shares
4,400,000
Price
$11.38
Total Value
$50.07M
Shares Held After
25,306,689
% of Holdings
17.4%
Adagene Inc. (ADAG)
DO CUONG V — Director
Shares
2,000
Price
$3.75
Total Value
$7.50K
Shares Held After
2,000
% of Holdings
100.0%
Verrica Pharmaceuticals Inc. (VRCA)
Rieger Jayson — Director
Shares
20,000
Price
$5.06
Total Value
$101.20K
Shares Held After
202,593
% of Holdings
9.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
33,787
Price
$3.85
Total Value
$130.00K
Shares Held After
581,059
% of Holdings
5.8%
Apollomics Inc. (APLM)
Chen Hung-Wen — Director
Shares
266,667
Price
$15.00
Total Value
$4.00M
Shares Held After
1,029,695
% of Holdings
25.9%
Apollomics Inc. (APLM)
Chen Hung-Wen — Director
Shares
103,333
Price
$15.00
Total Value
$1.55M
Shares Held After
418,334
% of Holdings
24.7%
Apollomics Inc. (APLM)
Chen Hung-Wen — Director
Shares
166,667
Price
$12.00
Total Value
$2.00M
Shares Held After
315,001
% of Holdings
52.9%
Apollomics Inc. (APLM)
LIN PETER KUAN-HOW — Chief Financial Officer
Shares
26,667
Price
$15.00
Total Value
$400.00K
Shares Held After
48,979
% of Holdings
54.4%
Apollomics Inc. (APLM)
Chen Yi-Kuei — Director
Shares
20,000
Price
$15.00
Total Value
$300.00K
Shares Held After
121,248
% of Holdings
16.5%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
12,000
Price
$3.79
Total Value
$45.46K
Shares Held After
3,084,000
% of Holdings
0.4%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
37,200
Price
$10.32
Total Value
$383.90K
Shares Held After
482,800
% of Holdings
7.7%
VERU INC. (VERU)
BARNETTE K GARY — Chief Scientific Officer
Shares
1,800
Price
$2.69
Total Value
$4.84K
Shares Held After
2,300
% of Holdings
78.3%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$0.92
Total Value
$1.75K
Shares Held After
375,785
% of Holdings
0.5%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$2.95
Total Value
$44.25K
Shares Held After
62,500
% of Holdings
24.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
951
Price
$71.50
Total Value
$68.00K
Shares Held After
494,887
% of Holdings
0.2%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
2,525,252
Price
$0.99
Total Value
$2.50M
Shares Held After
24,617,320
% of Holdings
10.3%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
46,387
Price
$10.37
Total Value
$481.03K
Shares Held After
1,319,784
% of Holdings
3.5%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
460,000
Price
$0.64
Total Value
$292.10K
Shares Held After
1,343,886
% of Holdings
34.2%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,220
Price
$0.32
Total Value
$710.40
Shares Held After
34,199
% of Holdings
6.5%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
2,600
Price
$9.63
Total Value
$25.04K
Shares Held After
77,900
% of Holdings
3.3%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
1,462
Price
$13.19
Total Value
$19.28K
Shares Held After
1,544,980
% of Holdings
0.1%
Ensysce Biosciences, Inc. (ENSC)
GOWER BOB G — Director
Shares
400,000
Price
$0.49
Total Value
$198.00K
Shares Held After
916,740
% of Holdings
43.6%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
3,500
Price
$8.62
Total Value
$30.17K
Shares Held After
83,500
% of Holdings
4.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
34,000
Price
$8.62
Total Value
$293.05K
Shares Held After
790,000
% of Holdings
4.3%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
5,222
Price
$11.40
Total Value
$59.53K
Shares Held After
1,543,518
% of Holdings
0.3%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
685
Price
$0.22
Total Value
$150.70
Shares Held After
31,979
% of Holdings
2.1%
ProMIS Neurosciences Inc. (PMN)
Kaplan Johanne — Chief Development Officer
Shares
2,280
Price
$13.30
Total Value
$30.32K
Shares Held After
6,221
% of Holdings
36.7%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
5,000
Price
$0.26
Total Value
$1.29K
Shares Held After
31,294
% of Holdings
16.0%
Showing 1–50 of 394 transactions (page 1 of 8)